Krystal Biotech, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.01x
Net debt / equity: -0.39x
Debt / assets: 0.01x
Debt / EBITDA: 0.05x
Net debt / EBITDA: -2.45x

Liquidity & coverage

Current ratio: 9.46x
Quick ratio: 9.06x
Cash ratio: 7.64x
Interest coverage: —
EBITDA / interest: —
Working capital: $911.9M

Cash & dividend

FCF / debt: 26.05x
Cash flow / debt: 27.47x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.